Literature DB >> 26494626

Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation.

Gennaro Prota1, Dennis Christensen2, Peter Andersen2, Donata Medaglini1, Annalisa Ciabattini3.   

Abstract

CD4(+) T-cell priming is an essential step in vaccination due to the key role of T helper cells in driving both effector and memory immune responses. Here we have characterized in C57BL/6 mice the T helper subtype differentiation among tetramer-specific CD4(+) T cells primed by subcutaneous immunization with the tuberculosis vaccine antigen H56 plus the adjuvant CAF01. Peptide-specific population identified by the MHC class II tetramers differentiated into several T helper subtypes upon antigen encounter, and the frequency of subpopulations differed according to their localization. Th1 (CXCR3(+)T-bet(+)), Tfh (CXCR5(+)PD-1(+)Bcl-6(+)) and RORγt(+) cells were induced in the lymph nodes draining the immunization site (dLN), while Th1 cells were the predominant subtype in the spleen. In addition, CD4(+) T cells co-expressing multiple T-cell lineage-specifying transcription factors were also detected. In the lungs, most of the tetramer-binding T cells were RORγt(+), while Tfh and Th1 cells were absent. After boosting, a higher frequency of tetramer-binding cells co-expressing the markers CD44 and CD127 was detected compared to primed cells, and cells showed a prevalent Th1 phenotype in both dLN and spleens, while Tfh cells were significantly reduced. In conclusion, these data demonstrate that parenteral immunization with H56 and CAF01 elicits a distribution of antigen-specific CD4(+) T cells in both lymphoid tissues and lungs, and gives rise to multiple T helper subtypes, that differ depending on localization and following reactivation.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  CD4(+) T cell priming; MHC class II tetramers; Subcutaneous immunization; T helper subsets

Mesh:

Substances:

Year:  2015        PMID: 26494626     DOI: 10.1016/j.vaccine.2015.09.024

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Modulation of Primary Immune Response by Different Vaccine Adjuvants.

Authors:  Annalisa Ciabattini; Elena Pettini; Fabio Fiorino; Gabiria Pastore; Peter Andersen; Gianni Pozzi; Donata Medaglini
Journal:  Front Immunol       Date:  2016-10-17       Impact factor: 7.561

2.  Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.

Authors:  David J Dowling; Evan A Scott; Annette Scheid; Ilana Bergelson; Sweta Joshi; Carlo Pietrasanta; Spencer Brightman; Guzman Sanchez-Schmitz; Simon D Van Haren; Jana Ninković; Dina Kats; Cristiana Guiducci; Alexandre de Titta; Daniel K Bonner; Sachiko Hirosue; Melody A Swartz; Jeffrey A Hubbell; Ofer Levy
Journal:  J Allergy Clin Immunol       Date:  2017-03-23       Impact factor: 10.793

Review 3.  Trying to See the Forest through the Trees: Deciphering the Nature of Memory Immunity to Mycobacterium tuberculosis.

Authors:  Ian M Orme; Marcela I Henao-Tamayo
Journal:  Front Immunol       Date:  2018-03-08       Impact factor: 7.561

4.  Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System.

Authors:  Annalisa Ciabattini; Elena Pettini; Fabio Fiorino; Simone Lucchesi; Gabiria Pastore; Jlenia Brunetti; Francesco Santoro; Peter Andersen; Luisa Bracci; Gianni Pozzi; Donata Medaglini
Journal:  Front Immunol       Date:  2018-03-12       Impact factor: 7.561

5.  Transcriptomics of the Vaccine Immune Response: Priming With Adjuvant Modulates Recall Innate Responses After Boosting.

Authors:  Francesco Santoro; Elena Pettini; Dmitri Kazmin; Annalisa Ciabattini; Fabio Fiorino; Gregor D Gilfillan; Ida M Evenroed; Peter Andersen; Gianni Pozzi; Donata Medaglini
Journal:  Front Immunol       Date:  2018-06-05       Impact factor: 7.561

6.  Optimized Protocol for the Detection of Multifunctional Epitope-Specific CD4+ T Cells Combining MHC-II Tetramer and Intracellular Cytokine Staining Technologies.

Authors:  Gabiria Pastore; Monica Carraro; Elena Pettini; Emanuele Nolfi; Donata Medaglini; Annalisa Ciabattini
Journal:  Front Immunol       Date:  2019-10-09       Impact factor: 7.561

7.  T Cells Primed by Live Mycobacteria Versus a Tuberculosis Subunit Vaccine Exhibit Distinct Functional Properties.

Authors:  Thomas Lindenstrøm; Albanus Moguche; Mie Damborg; Else Marie Agger; Kevin Urdahl; Peter Andersen
Journal:  EBioMedicine       Date:  2017-12-07       Impact factor: 8.143

8.  Airway delivery of both a BCG prime and adenoviral boost drives CD4 and CD8 T cells into the lung tissue parenchyma.

Authors:  Daryan A Kaveh; M Carmen Garcia-Pelayo; Naomi C Bull; Pedro J Sanchez-Cordon; John Spiropoulos; Philip J Hogarth
Journal:  Sci Rep       Date:  2020-10-30       Impact factor: 4.996

9.  Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?

Authors:  Elena Pettini; Gabiria Pastore; Fabio Fiorino; Donata Medaglini; Annalisa Ciabattini
Journal:  Vaccines (Basel)       Date:  2021-03-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.